Suppr超能文献

[临床试验中的安慰剂效应与不良反应]

[Placebo effects and adverse effects in clinical trials].

作者信息

Weihrauch T R

机构信息

Pharma-Forschungszentrum Bayer AG, Wuppertal.

出版信息

Med Klin (Munich). 2000 May;95(1 Spec No):23-30.

Abstract

BACKGROUND

It is well known that placebos evoke a variety of effects in the human body. It is less known that placebo medication can produce adverse drug reactions (ADRs).

METHOD

The efficacy and, as the main topic, the tolerability were investigated from an international clinical data pool on placebo-controlled randomized multicenter studies of 5 different groups of indications. The therapeutic areas analyzed were neuropsychiatry (nimodipine, ipsapirone), cardiology (nisoldipine), metabolism (acarbose) and gastroenterology (hydrotalcit).

RESULTS

The placebo efficacy was evident and varied not only in comparison to 5 indication groups analyzed, but also within them. Placebo showed for example hardly an effect on the symptomatology of stroke patients with a severe neurological deficit in comparison to verum while there was a 50% improvement in symptoms following placebo application in patients with a mild stroke. In angina patients exercise tolerance increased under placebo by 10% (time to onset of ST segment depression and symptoms of angina) while verum showed a 22% improvement. In diabetes placebo had no effect as compared to baseline and to a verum on blood glucose and HbA1C. ADRs could be observed under placebo treatment. The frequency and kind of placebo-induced ADRs varied also between the indication groups, i.e. typical CV side-effects were observed in CV controls. The placebo ADR profile was similar to the reference drug also. Some ADRs were reported even more frequently under placebo than under verum, like "dry mouth" in patients with general anxiety status.

CONCLUSIONS

Placebo therapy is frequently effective and is not a "non-therapy". Placebo effects can be shown only by direct comparison with a "non-therapy". A placebo therapy is frequently accompanied by adverse drug reactions (ADRs) just as a verum therapy. Placebo ADRs are frequently illness- and verum-specific. Effects and ADRs of placebo therapy must be known, to judge the effect of verum medication in controlled clinical trials. The mechanisms of placebo effects are manifold (e.g. endorphine release, conditioned learning). Since placebo therapy outside of evidence-based medicine (use of drugs without proven efficacy = pseudoplacebos) may potentially also cause serious side effects, the use may not only be useless but also harmful.

摘要

背景

众所周知,安慰剂会在人体内引发多种效应。而鲜为人知的是,安慰剂药物也会产生药物不良反应(ADR)。

方法

从一个国际临床数据库中,对5组不同适应症的安慰剂对照随机多中心研究的疗效以及作为主要主题的耐受性进行了调查。所分析的治疗领域包括神经精神病学(尼莫地平、伊沙匹隆)、心脏病学(尼索地平)、代谢(阿卡波糖)和胃肠病学(铝碳酸镁)。

结果

安慰剂的疗效是明显的,不仅在与所分析的5个适应症组比较时有所不同,而且在各适应症组内部也存在差异。例如,与真药相比,安慰剂对有严重神经功能缺损的中风患者的症状几乎没有影响,而对轻度中风患者使用安慰剂后症状有50%的改善。在心绞痛患者中,安慰剂使运动耐量提高了10%(ST段压低和心绞痛症状出现的时间),而真药则有22%的改善。在糖尿病患者中,与基线和真药相比,安慰剂对血糖和糖化血红蛋白没有影响。在安慰剂治疗下可观察到药物不良反应。安慰剂诱发的药物不良反应的频率和种类在不同适应症组之间也有所不同,例如在心血管病对照组中观察到典型的心血管副作用。安慰剂的药物不良反应特征也与参比药物相似。有些药物不良反应在安慰剂组的报告频率甚至比真药组更高,如在广泛性焦虑状态患者中出现的“口干”。

结论

安慰剂治疗常常是有效的,并非“无治疗作用”。安慰剂效应只有通过与“无治疗”进行直接比较才能显现出来。与真药治疗一样,安慰剂治疗常常伴有药物不良反应。安慰剂引起的药物不良反应常常具有疾病特异性和真药特异性。为了在对照临床试验中判断真药治疗的效果,必须了解安慰剂治疗的效应和药物不良反应。安慰剂效应的机制是多方面的(如内啡肽释放、条件学习)。由于循证医学之外的安慰剂治疗(使用未经证实疗效的药物 = 假安慰剂)可能也会潜在地导致严重副作用,其使用可能不仅无效而且有害。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验